title: Rectal perforation associated with sunitinib therapy.
authors.forename: Rocío
authors.initials: R
authors.lastname: Santos-Rancaño
authors.forename: Jaime
authors.initials: J
authors.lastname: Zuloaga
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Sanz-Ortega
authors.forename: Mario
authors.initials: M
authors.lastname: Ortega
authors.forename: Fernando
authors.initials: F
authors.lastname: Jiménez
authors.forename: Mauricio
authors.initials: M
authors.lastname: García-Alonso
authors.forename: Fernando
authors.initials: F
authors.lastname: Esteban
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Sanz
authors.forename: Carlos
authors.initials: C
authors.lastname: Cerdán-Santacruz
authors.forename: Javier
authors.initials: J
authors.lastname: Cerdán-Miguel
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007416:Intestinal Perforation / Q000139:chemically induced*; D008297:Male; D011758:Pyrroles / Q000009:adverse effects*; D012002:Rectal Diseases / Q000139:chemically induced*; D000077210:Sunitinib
chemical_list: D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib